H Grant Skaggs Jr
Examiner (ID: 16447)
Most Active Art Unit | 3101 |
Art Unit(s) | 3651, 1301, 3615, 3653, 2899, 3101 |
Total Applications | 2062 |
Issued Applications | 1836 |
Pending Applications | 39 |
Abandoned Applications | 187 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7111727
[patent_doc_number] => 20050209183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Cosmetic or pharmaceutical preparations comprising nucleic acids based on non-methylated CPG motifs'
[patent_app_type] => utility
[patent_app_number] => 11/040373
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9804
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040373 | Cosmetic or pharmaceutical preparations comprising nucleic acids based on non-methylated CPG motifs | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7111727
[patent_doc_number] => 20050209183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Cosmetic or pharmaceutical preparations comprising nucleic acids based on non-methylated CPG motifs'
[patent_app_type] => utility
[patent_app_number] => 11/040373
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9804
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040373 | Cosmetic or pharmaceutical preparations comprising nucleic acids based on non-methylated CPG motifs | Jan 20, 2005 | Abandoned |
Array
(
[id] => 4765045
[patent_doc_number] => 20080176256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Method For Detecting Prp Using at Least One Positive Charge and/or at Least One Glycosidic Bond and a Ligand Other Than a Protein Ligand'
[patent_app_type] => utility
[patent_app_number] => 10/583891
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11237
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176256.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583891
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583891 | Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand | Jan 18, 2005 | Issued |
Array
(
[id] => 5819958
[patent_doc_number] => 20060024271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Treatments for viral infections using IFN cytokines and ribavirin, alone or in combination'
[patent_app_type] => utility
[patent_app_number] => 11/033828
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6092
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024271.pdf
[firstpage_image] =>[orig_patent_app_number] => 11033828
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/033828 | Treatments for viral infections using IFN cytokines and ribavirin, alone or in combination | Jan 12, 2005 | Abandoned |
Array
(
[id] => 5726911
[patent_doc_number] => 20060057671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Immobilized probes and methods of detecting conformationally altered prion proteins'
[patent_app_type] => utility
[patent_app_number] => 11/030300
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 19361
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057671.pdf
[firstpage_image] =>[orig_patent_app_number] => 11030300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/030300 | Immobilized probes and methods of detecting conformationally altered prion proteins | Jan 6, 2005 | Abandoned |
Array
(
[id] => 7046128
[patent_doc_number] => 20050250723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Immunostimulation by chemically modified RNA'
[patent_app_type] => utility
[patent_app_number] => 11/025858
[patent_app_country] => US
[patent_app_date] => 2004-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11115
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250723.pdf
[firstpage_image] =>[orig_patent_app_number] => 11025858
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/025858 | Immunostimulation by chemically modified RNA | Dec 27, 2004 | Abandoned |
Array
(
[id] => 6931728
[patent_doc_number] => 20050282763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Methods of treating bladder disorders'
[patent_app_type] => utility
[patent_app_number] => 11/019955
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10480
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282763.pdf
[firstpage_image] =>[orig_patent_app_number] => 11019955
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/019955 | Methods of treating bladder disorders | Dec 21, 2004 | Abandoned |
Array
(
[id] => 6931705
[patent_doc_number] => 20050282740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Methods and compositions for regulating protein-protein interactions'
[patent_app_type] => utility
[patent_app_number] => 11/022308
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20265
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282740.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022308
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022308 | Methods and compositions for regulating protein-protein interactions | Dec 20, 2004 | Abandoned |
Array
(
[id] => 415381
[patent_doc_number] => 07279565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-09
[patent_title] => 'Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress'
[patent_app_type] => utility
[patent_app_number] => 10/996420
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16724
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/279/07279565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10996420
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/996420 | Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress | Nov 25, 2004 | Issued |
Array
(
[id] => 7097201
[patent_doc_number] => 20050129659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections'
[patent_app_type] => utility
[patent_app_number] => 10/993212
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8578
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10993212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/993212 | Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections | Nov 18, 2004 | Issued |
Array
(
[id] => 9059641
[patent_doc_number] => 08546075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Method of detecting hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 10/577853
[patent_app_country] => US
[patent_app_date] => 2004-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 14846
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10577853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577853 | Method of detecting hepatitis C virus | Oct 27, 2004 | Issued |
Array
(
[id] => 9254394
[patent_doc_number] => 08617805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-31
[patent_title] => 'Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture'
[patent_app_type] => utility
[patent_app_number] => 10/971933
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 22308
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10971933
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/971933 | Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture | Oct 21, 2004 | Issued |
Array
(
[id] => 7237858
[patent_doc_number] => 20050080040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Treatment of tissue, instruments and work surfaces to remove infectious agents'
[patent_app_type] => utility
[patent_app_number] => 10/959549
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11129
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10959549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/959549 | Treatment of tissue, instruments and work surfaces to remove infectious agents | Oct 4, 2004 | Abandoned |
Array
(
[id] => 5258731
[patent_doc_number] => 20070212363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Immunoglobulins with Potent and Broad Antiviral Activity'
[patent_app_type] => utility
[patent_app_number] => 10/573962
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8942
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212363.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573962 | Immunoglobulins with Potent and Broad Antiviral Activity | Sep 28, 2004 | Abandoned |
Array
(
[id] => 4704120
[patent_doc_number] => 20080063643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Peptide Derived From Hepatitis C Virus'
[patent_app_type] => utility
[patent_app_number] => 10/573032
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 13783
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20080063643.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573032 | Peptide Derived From Hepatitis C Virus | Sep 21, 2004 | Abandoned |
Array
(
[id] => 4812847
[patent_doc_number] => 20080193478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Inactivated Poliomyelitis Vaccine Derived From Sabin Strain Of Polio Virus'
[patent_app_type] => utility
[patent_app_number] => 11/661523
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4272
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193478.pdf
[firstpage_image] =>[orig_patent_app_number] => 11661523
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/661523 | Inactivated Poliomyelitis Vaccine Derived From Sabin Strain Of Polio Virus | Aug 26, 2004 | Abandoned |
Array
(
[id] => 6918730
[patent_doc_number] => 20050096291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Oligonucleotide analog and method for treating flavivirus infections'
[patent_app_type] => utility
[patent_app_number] => 10/913996
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14645
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096291.pdf
[firstpage_image] =>[orig_patent_app_number] => 10913996
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/913996 | Oligonucleotide analog and method for treating flavivirus infections | Aug 4, 2004 | Issued |
Array
(
[id] => 5120597
[patent_doc_number] => 20070142312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Antigen delivery system'
[patent_app_type] => utility
[patent_app_number] => 10/566866
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9732
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566866
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566866 | Antigen delivery system | Aug 4, 2004 | Abandoned |
Array
(
[id] => 4989342
[patent_doc_number] => 20070155683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Artificial cpg single-stranded oligodeoxynucleotide and antiviral use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/565718
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5196
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565718
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565718 | Artificial cpg single-stranded oligodeoxynucleotide and antiviral use thereof | Jul 25, 2004 | Issued |
Array
(
[id] => 7168472
[patent_doc_number] => 20050202036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Alternate reading frame polypeptides drived from hepatitis C and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 10/897680
[patent_app_country] => US
[patent_app_date] => 2004-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22597
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10897680
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/897680 | Alternate reading frame polypeptides drived from hepatitis C and methods of their use | Jul 21, 2004 | Abandoned |